June 4, 2020 - Chair’s Summary

1. The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic.

2. The Summit brought together more than 300 people, including 42 Heads of State and Government. 62 countries were represented, notably 14 Gavi implementing countries, all of the G7 nations and 19 governments of the G20. Eminent participants also included H.E. Antonio Guterres, Secretary-General of the United Nations; H.E. Moussa Faki Mahamat, Chairperson of the African Union Commission; H.E. Dr Tedros Adhanom Ghebreyesus, WHO Director-General; H.E. Henrietta Fore, UNICEF Executive Director; Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation; Ministers from implementing and donor countries; CEOs of vaccine manufacturing companies and private sector partners; leaders of UN and other international agencies; senior civil society representatives; and Gavi champions. A full list of the participants can be found in Annex.

3. US$8.8 billion worth of new commitments were pledged by public and private sector donors

towards Gavi’s replenishment, well exceeding the target set in support of Gavi’s investment opportunity for the next 5 years. These pledges will add to the US$1.7 billion previously secured by Gavi1, bringing its resources for 2021-2025 to more than US$10.5 billion. Gavi is now well positioned to accelerate the roll out of current vaccines, reach 300 million more children in developing countries by 2025, and in so doing contribute to saving 7 to 8 million lives.

4. As part of the new pledges, Italy, Norway, Spain and The Netherlands committed US$926 million to Gavi’s International Finance Facility for Immunisation (IFFIm), significantly exceeding the ask to replenish IFFIm with at least US$500 million. In addition, commitments from the Bill & Melinda Gates Foundation, Japan, The Netherlands, Norway and the UK included US$158 million for the Gavi Matching Fund, an innovative finance instrument which doubles the impact of private sector partnerships in immunisation, doubling the level of funding for this instrument compared to the previous period.

5. In addition to the replenishment funding, more than US$0.5 billion of additional resources were pledged to fund the newly launched Gavi COVAX AMC, an innovative financial instrument to accelerate access to COVID-19 vaccines to fight the pandemic in developing countries.

1 Resources previously committed consist mainly of proceeds from long-term donor pledges to the International Finance Facility

for Immunisation (IFFIm), investment income, and a drawdown from Gavi’s cash and investment reserve.

6. Besides receiving strong endorsements from long-standing Gavi donors, the Summit welcomed

eight new sovereign donors who made pledges to Gavi for the first time, including Bhutan, Burkina Faso, Cameroon, Finland, Greece, New Zealand, Portugal and Uganda.

7. Participants recognized the significant commitment of implementing countries, that will invest an expected US$3.6 billion in domestic co-financing and self-funded vaccine programmes, more than double the amount for the previous five-year period. This investment may be impacted by the economic effects of the COVID-19 pandemic. Participants also welcomed new commitments made by the pharmaceutical industry to further invest in R&D and production and supply a range of vaccines in significant quantities to Gavi. With active work between Alliance Partners including HPV vaccine manufacturers, Gavi will have the potential to increase its HPV vaccination reach from 50 million girls to 84 million girls between 2021-2025 – averting close to an additional 500,000 future deaths thanks to improved supply availability during Gavi’s next strategic period.

8. Throughout the Summit, donor Governments confirmed their strong endorsement for Gavi and pledged their financial support. Messages were shared by many donor Heads of State and Government, including the Prime Minister of Australia; the President of Burkina Faso; the Prime Minister of Canada; the Premier of the State Council of the People’s Republic of China; the President of the European Commission; the President of France; the Chancellor of Germany; the Prime Minister of Iceland; the Prime Minister of India; the Taoiseach of Ireland; the Prime Minister of Italy; the Prime Minister of Japan; the Prime Minister of Luxembourg; the Prince of Monaco; the Prime Minister of The Netherlands; the Prime Minister of New Zealand; the Prime Minister of Norway; the Emir of the State of Qatar; the Prime Minister of Spain; the Prime Minister of Sweden; the President of Switzerland; the President of Turkey; the Prime Minister of the United Kingdom; and the President of the United States. A number of donor countries were also represented by their Ministers.

9. In his welcome address, Prime Minister Johnson noted the importance of the Global Vaccine Summit at a critical moment in time. He expressed his enthusiasm to continue working closely with Gavi in its next strategic period and reminded the audience of the need to build on successful existing innovative partnerships such as Gavi, which were particularly important in addressing emerging issues such as COVID-19. Dr Ngozi Okonjo-Iweala, Gavi’s Board Chair, recapped Gavi’s significant impact over its first 20 years and delivered a message of hope for the future. The United Nations Secretary-General reiterated the UN’s support for Gavi’s work to immunise millions of children in lower income countries. H.E. Donald Trump, President of the United States, praised the transparency in the Gavi model and H.E. Erna Solberg, Prime Minister of Norway, expressed Norway’s long-term commitment to the Vaccine Alliance. The Chairperson of the African Union Commission called on participants to provide significant support to Gavi’s work. Summit participants heard about the critical role played by civil society organisations who partner at every step of the Gavi model.

10. Participants underlined Gavi’s critical mission to prevent disease. Dr Tedros Adhanom, Director-General of WHO and H.E. Nana Akufo-Addo, President of Ghana shared their reflexions. The Rt. Hon. Anne-Marie Trevelyan, UK Secretary of State for International Development, Dr Seth Berkley, CEO of Gavi, and Dr Emma Walmsley, CEO of GlaxoSmithKline, debated the importance of Gavi’s role in shaping markets to ensure an equitable access to essential vaccines. H.E. Sheikh Hasina, Prime Minister of Bangladesh, offered reflections on Gavi’s impact on the ground. H.E. Faustin-Archange Touadéra, President of the Central African Republic, H.E. Mahamadou Issoufou, President of Niger, H.E. Macky Sall, President of Senegal, H.E. Gotabaya Rajapaksa, President of Sri Lanka, and Joyce L. Kilikpo, Executive Director of Public Health Initiative Liberia, exchanged thoughts on Gavi’s role in protecting the world against health insecurity and pandemics. Participants listened to testimonies from the front line in the fight against Ebola. Dr Ngozi Okonjo-Iweala, Gavi’s Board Chair, shared her views on Gavi’s impact.

11. Gavi’s ability to protect communities was applauded. H.E. Roch Marc Christian Kaboré, President of Burkina Faso, made a strong plea for continued support from the international community, pointing to the successes achieved and reminding the audience of the Summit of the road ahead. H.E. Uhuru Kenyatta, President of Kenya, H.E. Filipe Nyusi, President of Mozambique, and H.E. Julius Maada Bio, President of Sierra Leone, were joined by Henrietta Fore, Executive Director of UNICEF and Lubna Hashmat, Chief Executive of CHIP, in emphasizing the critical goal of reaching the unreached. Anuradha Gupta, Deputy CEO of Gavi, reminded the audience that nearly 10.5 million “zero dose” children, often concentrated in marginalised and disadvantaged communities, are still not receiving their first dose of DTP vaccine. Norwegian Minister for International Development Dag Inge Ulstein, joined by IFFIm Board Chair Cyrus Ardalan, SEB CEO Johan Torgeby and Gavi’s Managing Director for resource mobilisation, private sector partnerships and innovative finance Marie-Ange Saraka-Yao, underlined the impact of Gavi’s innovative financial instruments.

12. The Summit recognized that in pursuing its mission, Gavi is enabling communities to prosper. In

this regard, participants reiterated their support for Gavi’s innovation work to digitally equip front line health care workers, advance diseases surveillance, scale communication to combat misinformation, create deeper community engagements, and achieve well-managed and robust delivery system are all essential for a successful vaccine deployment. Dr Ngozi Okonjo-Iweala was joined by Unilever’s CEO Alan Jope, Mastercard’s Vice-Chairman and President Michael Froman and Nexleaf CEO Nithya Ramanathan to celebrate the power of the private sector to bring innovations and contribute to Gavi’s achievements. Several new collaborations with the private sector were announced. H.E. Sahle-Work Zewde, President of Ethiopia, challenged Summit participants to support immunization and foster prosperity.

13. The Summit also discussed the global response to COVID-19. Kate Bingham, Head of the UK

Vaccine Task Force, set out the challenges and opportunities that vaccines against COVID-19 would present. H.M. King Abdullah II of Jordan, H.E. Abdel Fattah el-Sisi, President of Egypt, H.E. Mohamed Farmajo, President of Somalia and H.E. Lee Hsien Loong, Prime Minister of Singapore, called on the global community to work together to accelerate access to COVID-19 vaccines for all. This message was also conveyed by H.E. Angela Merkel, Chancellor of Germany, H.E. Giuseppe Conte, Prime Minister of Italy, and other world leaders throughout the conference. Richard Hatchett, CEO of CEPI, and Seth Berkley, CEO of Gavi, presented their common work under the umbrella of the Access to COVID-19 Tools (ACT) Accelerator Vaccine Taskforce.

14. Dr Berkley announced the launch of the COVID-19 Vaccine Global Access Facility (COVAX Facility). Its objective is to accelerate equitable access to appropriate, safe and efficacious COVID-19 vaccines for all countries. Higher income countries will use domestic resources to contribute funds to the advance purchase guarantees and will purchase vaccines side by side with Gavi-supported countries who will use ODA resources. Manufacturers’ interest was recognized, as producers are seeking volume guarantees to scale production and understanding the risk of only serving a few countries in times of global pandemic and want to work with the Facility. The new initiative is leveraging Gavi’s track record in working with the world’s vaccine manufacturers and other industry stakeholders to help create the right conditions that enable production at the necessary volumes to meet demand.

15. The Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi COVAX AMC) was launched. The launch builds on the successes of Gavi’s pneumococcal Advance Market Commitment (PCV AMC), which has helped vaccinate an estimated 225 million children across 60 low and lower-middle income countries against the leading cause of childhood pneumonia. H.E. Paul Kagame, President of Rwanda, H.E. Giuseppe Conte, Prime Minister of Italy, H.E. Mikhail Murashko, Minister of Health of Russia, Mari Pangestu, Managing Director of the World Bank, and Dr Ngozi Okonjo-Iweala, Gavi Board Chair, were joined by Pascal Soriot, CEO of Astra Zeneca, Sai D. Prasad, President of DCVMN and Thomas B. Cueni, Director-General of IFPMA, and shared their views. The new AMC required seed funding of $2bn to jumpstart vaccine guarantees and to purchase vaccines when available to immunise health care workers, high risk groups and create a flexible vaccine

buffer to be deployed where it is needed most. AstraZeneca made the first private sector commitment and will guarantee 300 million doses of the COVID-19 vaccine it is developing in collaboration with the University of Oxford.

16. Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation, provided a strong message of support for Gavi’s mission and reminded participants that Gavi was their largest and best investment and that if Gavi didn’t exist, it would have to be created for COVID-19. The Rt Hon Boris Johnson, Prime Minister of the UK, announced the final pledging outcomes and Dr Ngozi, Gavi Board Chair, warmly thanked speakers and participants for their commitments. They agreed that this Global Vaccine Summit was a watershed in recognising and resourcing the power of immunisation. The COVID-19 pandemic demonstrated the critical role of vaccination, not only in protecting people and saving lives, but also in reducing the growing threat to global health security and boosting the global economy.

17. Throughout the Summit, messages of support were received from the Heads of State or Heads of Government of Argentina, Bhutan, Chad, Georgia, Mauritania, Nepal, Nigeria and Zambia, and ministers and senior representatives from Brazil, Indonesia, Mexico, Pakistan, Papua New Guinea, South Africa, the USA, Zimbabwe, and the Wellcome Trust. Participants expressed their deep appreciation for the leadership and unwavering support of the Government of the UK and Vaccine Alliance partners for their contributions to make the Global Vaccine Summit a success.

Global Vaccine Summit – Participants List

Government and Regional Organisations

Afghanistan

HE Mohamad Ashraf Ghani, President

HE Dr Ferozuddin Feroz, Minister of Public Health

Mr Ghulam Dastagir Nazary, National EPI Director

Dr Pratap Kumar Sahoo, Special Adviser to Gavi Board member-EMRO

Dr Najla Ahrari, Gavi Coordinator & Focal Point

African Union

HE Moussa Faki Mahamat, Chairperson

HE Amira Elfadil, Commissioner for Social Affairs

Dr Margaret Agama-Anyetei, Head of Health, Nutrition and Population Division

Ms Ebba Kalondo, Spokesperson, AUC Chairperson

Argentina

HE Gines Gonzalez Garcia, Minister of Health

Australia

HE The Hon. Scott Morrison, Prime Minister

Ms Sarah Goulding, Assistant Secretary

Bahrain

H.E. Ms Faeqa Saeed Al Saleh, Minister of Health

HE Lieutenant General Dr Sheikh Mohamed bin Abdullah Al-Khalifa, Chairman of the Supreme Council of

Health

HE Dr Maryam Alhajeri, Assistant Under Secretary for Public Health, Ministry of Health

Bangladesh

HE Sheikh Hasina, Prime Minister

Prof AFM Ruhal Haque M., Gavi Board Member

Bhutan

HE Dr Lotay Tshering, Prime Minister

Brazil

HE Eduardo Pazuello, Acting Minister of Health

Ms Rebecca Pacheco, International Advisor, Ministry of Health

Mr Luis Dias, Advisor, Ministry of Health

Mrs Tatiana Estrela, Officer of International Affairs, Ministry of Health

Burkina Faso

HE Roch Marc Christian Kaboré, President

Prof Nicolas MEDA, Senior Advisor Human Capital Development

Cameroon

HE Paul Biya, President

HE Paul Elung, Minister Assistant Secretary General

Canada

HE Rt Hon Justin Trudeau, Prime Minister

Mrs Megan Cain, Director, Implementation, Health and Nutrition Bureau

Central African Republic

HE Faustin-Archange Touadéra, President

Chad

HE Idriss Deby Itno, President

HE Prof Mahamoud Youssouf Khayal, Minister of Health

China

HE Keqiang Li, Premier of the State Council

HE Dr Xiaowei Ma, Minister

HE Xu Chen, Ambassador and Permanent Representative, Geneva

Mr Limin Zhang, Political Counsellor, Chinese Embassy in the UK

Denmark

HE Rasmus Prehn, Minister for Development Cooperation

Egypt

HE Abdel Fattah El-Sisi, President

European Commission

HE Ursula Von der Leyen, President

Mrs Marjeta Jager, Deputy Director-General

Dr Jan Paehler, Head of Health Sector

Ethiopia

HE Sahle-Work Zewde, President

Fiji

HE Dr Ifereimi Waqainabete, Minister of Health

Finland

HE Ville Skinnari, Minister for Development Cooperation and Foreign Trade

Mr Pasi Poysari, Director, Unit for Sustainable Development and Climate Policy, Ministry for Foreign

Affairs of Finland

Ms Outi Kuivasniemi, Deputy Director for International Affairs, Ministry of Social Affairs and Health

Ms Sanni Mäntyniemi, Desk officer, Ministry for Foreign Affairs of Finland

France

HE Emmanuel Macron, President

HE Mrs Stéphanie Seydoux, Ambassador for Global Health, French ministry of Europe and foreign affairs

Mr Joan Valadou, Director for Human Development, Ministry of Europe and Foreign Affairs

Georgia

HE Giorgi Gakharia, Prime Minister

Germany

HE Angela Merkel, Chancellor

Mrs Birgit Pickel, Deputy Director General, Federal Ministry for Economic Cooperation and Development

Mrs Ilse Hahn, Head of Division Health, Population Policy and Social Protection, Federal Ministry for

Economic Cooperation and Development

Mr Alexander Freese, Senior Policy Officer, Federal Ministry for Economic Cooperation and Development

Mr Heiner Staschen, Counsellor, German Embassy in UK

Ms Britta Schlüter, Counsellor, German Embassy in UK

Ghana

HE Nana Dankwa Akufo-Addo, President

HE Kwaku Agyeman-Manu, Minister for Health

Greece

HE Kostas Fragogiannis, Deputy Foreign Minister for Economic Diplomacy and Openness

Honduras

Dr Edna Batres, Presidencial adviser on Health, Ministry of Health

Iceland

HE Katrín Jakobsdóttir, Prime Minister

India

HE Narendra Modi, Prime Minister

Ms Vandana Gurnani, Additional Secretary and Mission Director Ministry of Health and Family Welfare

Indonesia

HE Ltg (Ret.) Terawan Agus Putranto, Minister of Health

HE Mr Suharso Monoarfa, Minister for National Development Planning

Ireland

HE Leo Varadkar, Taoiseach

Mr Nick Reddy, Private Secretary to the Taoiseach

Ms Emma Warwick, Policy Lead - Global Health, HIV and AIDS, Department of Foreign Affairs and Trade

Mr Fergal Horgan, Global Health Advisor, Irish Aid, Department of Foreign Affairs and Trade

Italy

HE Giuseppe Conte, Prime Minister

Mrs Francesca Manno, Director, Ministry Economy and Finance, International Affair Office

Japan

HE ABE Shinzo, Prime Minister

HE YAMAZAKI Kazuyuki, Ambassador Extraordinary and Plenipotentiary, Permanent Representative of Japan to the International Organisations in Geneva

HE TSUKADA Tamaki, Director-General / Assistant Minister (Ambassador), Ministry of Foreign Affairs

Dr SAHARA Yasuyuki, Senior Assistant Minister, Ministry of Health, Labour and Welfare

Jordan

His Majesty King Abdullah II ibn Al Hussein of Jordan

Kenya

HE Uhuru Kenyatta, President

Sen Mutahi Kagwe, Cabinet Secretary, Ministry Of Health

Mrs Ruth Kagia, Deputy Chief of Staff, Office of the President

Korea

HE KANG, Kyung-wha, Minister of Foreign Affairs

Mr CHO, Yeong-moo, Director-General for Development Cooperation, Ministry of Foreign Affairs

Ms SHIN, Heesun, Counsellor, Permanent Mission of the Republic of Korea to the United Nations Office

and other international organizations in Geneva

Kuwait

Representative of His Highness the Amir of the State of Kuwait, HE Sheikh Dr Ahmed Nasser Al

Mohammad Al Sabah, Minister of Foreign affairs of the State of Kuwait

Dr Nada Almutawa, Member of the Board of Directors, Kuwait Fund for Arab Economic Development

Mr Abdulwahab A. Al-Bader, Director General of Kuwait Fund for Arab Economic Development

Lao People's Democratic Republic

HE Assoc Prof Dr Bounkong Syhavong, Minister of Health

Luxembourg

HE Xavier Bettel, Prime Minister

Mr Philippe Mores, Coordinator, Multilateral Affairs, Ministry of Foreign and European Affairs of

Luxembourg

Mrs Anne-Laure Theis, Health Focal Point, Ministry of Foreign and European Affairs of Luxembourg -

Development Cooperation

Mr Patrick Hemmer, Diplomatic Advisor PM Bettel

Mauritania

HE Mohamed Cheikh El Ghazouani, President

Mexico

HE Ms Lic Martha Delgado Peralta, Undersecretary for Multilateral Affairs and Human Rights

Ms Monica Valdez, Head of Political Affairs, Embassy of Mexico in UK

Monaco

HSH Prince Albert II

HE Carole Lanteri, Ambassador Extraordinary and Plenipotentiary, Permanent Representative

Mrs Emilie Larese-Silvestre, Program Coordinator

Morocco

HE Nasser Bourita, Minister of Foreign Affairs, African Cooperation and Moroccan Expatriates of the

Kingdom of Morocco

Mr Redouane Adghoughi, Director of European Affairs, Ministry of Foreign Affairs

Mrs Yasmina Benbrahim, Advisor to the Minister of Foreign Affairs

Mozambique

HE Filipe Nyusi, President

Myanmanr

HE Dr Myint Htwe, Union Minister, Ministry of Health and Sports

Nepal

HE The Right Honourable Mrs Bidya Devi Bhandari, President

HE Bhanu Bhakta Dhakal, Minister of Health Population

Mr Bikash Devkota, Division Chief, Ministry of Health and Population

Netherlands

HE Mark Rutte, Prime Minister

Mrs Hanke Nubé, Senior advisor Taskforce Women's Rights and Gender Equality, Ministry of Foreign

Affairs of the Netherlands

New Zealand

HE Rt Hon Jacinda Ardern, Prime Minister

HE Diana Reaich, Acting Ambassador, New Zealand Permanent Mission to Switzerland

Dr Lucy Richardson, Senior Advisor, New Zealand Permanent Mission to the United Nations at Geneva

Mr Peter Bartlett, Counsellor - Science and Innovation, Europe, Ministry of Business, Innovation and

Employment

Niger

HE Mahamadou Issoufou, President

Nigeria

HE Dr Osagie Ehanire, Minister of Health, Federal Ministry of Health

Norway

HE Erna Solberg, Prime Minister

HE Dag Inge Ulstein, Minister of International Development

HE Aksel Jakobsen, Deputy Minister, Minstry of Foreign Affairs

Oman

HE Dr Ahmed Mohammed Al Saidi, Minister of Health, Ministry of Health

HE Dr Mohammed Bin Saif Al Hosni, Undersecretary for Health Affairs

Dr Seif Al-Abri, Director General of Disease Surveillance and Control, Ministry of Health

Mr Bader Al Rawahi, Director, Communicable Diseases, Ministry of Health

Pakistan

HE Dr Zafar Mirza, Special Assistant to the Prime Minister on Health

HE Khalil Hashmi, Ambassador to the UN, Geneva

Papua New Guinea

Hon Jelta Wong MP, Minister for Health and HIV/AIDS

Portugal

HE Marta Temido, Minister of Health

HE Rui Macieira, Ambassador, Permanent Representative of Portugal to the UN

Mr Eduardo Pinto da Silva, First Secretary of Embassy, Permanent Mission of Portugal, Geneva

Qatar

His Highness Sheikh Tamim bin Hamad bin Khalifa Al Thani, The Emir of the State of Qatar

Dr Niklaus Eggenberger, Senior Expert Partnerships, Qatar Fund for Development

Russia

HE Mikhail Murashko, Minister of Health

Prof Aydar Ishmukhametov, Director-General, Federal State Budgetary Scientific Institution «Chumakov

Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian

Academy of Sciences» (FSBSI «Chumakov FSC R&D IBP RAS»)

Rwanda

HE Paul Kagame, President

HE Dr Daniel Ngamije, Minister of Health

Mrs Annette Gakwerere, Partnership Coordination, Ministry of Health

Mr Hassan Sibomana, EPI Manager

Saudi Arabia

HH Prince Faisal bin Farhan Al-Saud, Minister of Foreign Affairs

HE Reema Bandar Al Saud, Ambassador, Embassy of Saudi Arabia in the United States

Dr Khalid Alkhudairy, Managing Director and Vice Chairman, Saudi Fund for Development

Eng Faisal Alkahtani, Acting Director-General, Operations Department, Saudi Fund for Development

Mr Ibrahim Alsugair, Economic Advisor, Saudi Fund for Development

Senegal

HE Macky Sall, President

Sierra Leone

HE Julius Maada Bio, President

Singapore

HE Rt Hon Lee Hsien Loong, Prime Minister

Somalia

HE Mohamed Abdullahi Farmajo, President

South Africa

HE Dr Zwelini Mkhize, Minister of Health

Spain

HE Pedro Sanchez, Prime Minister

Ms Pilar Sanchez-Bella, Foreign Policy Advisor, Office of the Prime Minister

Sri Lanka

HE Gotabaya Rajapaksa, President

Sweden

HE Stefan Lövfen, Prime Minister

HE Karin Wallensteen, State Secretary

HE Dr Anders Nordström, Ambassador for Global Health, Ministry For Foreign Affairs

Ms Harriet Pedersen, Director, Ministry For Foreign Affairs

Ms Karin Westerberg, Senior Advisor, Ministry For Foreign Affairs

Switzerland

HE Simonetta Sommaruga, President

HE Nora Kronig Romero, Ambassador for Global Health, Federal Office of Public Health

Mrs Enrichetta Placella, Deputy Head Global Program Health, Swiss Agency for Development and

Cooperation

Ms Aurora Danese, Scientific assistant, Federal Office of Public Health

Tanzania

HON Ummy Mwalimu, Minister for health,Community Development, Gender, Elderly and Children

Turkey

HE Recep Tayyip Erdoğan, President

HE Dr Fahrettin Koca, Minister of Health

HE Sadik Arslan, Ambassador, Permanent Representative, Permanent Mission of Turkey to the UN in

Geneva

Uganda

HE Dr Aceng Jane Ruth, Minister of Health

United Arab Emirates

HE Reem Al Hashimy, Minister of State for International Cooperation

HE Sultan Al Shamsi, Assistant Minister of International Development

Ms Al Anood Al Abdool, Deputy Director, Foreign Assistance Affairs Department, Ministry of Foreign

Affairs and International Cooperation

United Kingdom

HE Rt Hon Boris Johnson, Prime Minister

HE Rt Hon Anne-Marie Trevelyan, Secretary of State for International Development

HE Rt Hon James Duddridge, DFID and FCO Minister of State

HE Rt Hon Wendy Morton, DFID and FCO Minister of State

HE Lt Col Rt Hon James Cleverly, DFID and FCO Minister of State

HE Baroness Elizabeth Sugg, Parliamentary Under-Secretary of State for International Development

Ms Sarah Champion, Member of Parliament

Dr Philippa Whitford, Member of Parliament

Mr Nick Dyer, DFID Permanent Secretary

Mr Richard Clarke, DFID Director General for Policy, Research and Humanitarian

Mr Darren Welch, DFID Policy Director

Mr Daniel Graymore, DFID Head of Global Funds Department

Mr Alastair King-Smith, FCO Deputy Director, International Engagement, Coronavirus cross-government

International Taskforce

Mr Joseph Bonner, DFID Head of Events

Ms Mayan Al-Shakarchy, DFID Global Vaccine Summit Team - Project Officer

Ms Sophie Bracken, DFID Global Vaccine Summit Team - Innovative Finance Policy Adviser

Mr Andrew Bushell, FCO Bilateral & Network Engagement Team

Mrs Susan Elden, DFID Senior Health Adviser

Mr Adam Farley, DFID Global Vaccine Summit Team Leader

Ms Elizabeth Heyes, DFID Assistant Private Secretary to the Special Advisers

Mr Will Holloway, DFID Special Adviser to Secretary of State

Mr Daniel Kibble, DFID Global Vaccine Summit Team - International Engagement Adviser

Ms Lucy Godfrey, DFID Global Vaccine Summit Team - Project Officer

Ms Ayesha Ragunathan, DFID Global Vaccine Summit Team - Programme Officer

Ms Agnes Reeve, DFID Private Secretary to the Secretary of State

Mr Tom Routledge, DFID Global Vaccine Summit Team - Project Officer

Ms Vanessa Shade, DFID Global Vaccine Summit Team - Policy Manager

Mr Nick Stokeld, FCO Bilateral & Network Engagement Team

Mr Will Sweet, DFID Special Adviser to the Secretary of State

United States of America

HE Donald J. Trump, President

HE Ms Bonnie Glick, Deputy Administrator United States Agency for International Development (USAID)

Ms Irene Koek, Senior Deputy Assistant Administrator, Global Health, United States Agency for

International Development (USAID)

Ms Elizabeth Noonan, Bureau of Global Health, United States Agency for International Development

(USAID)

Ms Anna Radivilova, Director for European Affairs, National Security Council

Yemen

Mr Nasser Baoom, Minister of Public health

Zambia

HE Edgar Chagwa Lungu, President

Zimbabwe

HE Dr Obadiah Moyo, Minister of Health and Child Care

Alliance Partners

UNICEF

Ms Henrietta Fore, Executive Director

Mrs Etleva Kadilli, Director, Supply Division

Dr Robin Nandy, Principal Advisor & Chief of Immunizations

World Bank Group

Dr Mari E. Pangestu, Managing Director For Development Policy & Partnerships

Ms Mamta Murthi, Vice President of Human Development

Dr Muhammad Ali Pate, Global Director, Health, Nutrition and Population (HNP) Global Practice

Dr Michael Ranson, Senior Economist (Health)

World Health Organization

Dr Tedros Adhanom Ghebreyesus, Director-General

Dr Soumya Swaminathan, Deputy Director General for Programmes

Mr Michel Zaffran, Director, Polio Eradication

Bill & Melinda Gates Foundation

Mr Bill Gates, Co-chair

Mr Mark Suzman, CEO

Dr Christopher Elias, President, Global Development

Mr Joe Cerrell, Managing Director, Global Policy & Advocacy

Mrs Violaine Mitchell, Director, Health Funds and Partnerships, Global Development

Ms Julie Bernstein, Deputy Director, Global Policy & Advocacy

Ms Magdalena Robert, Senior Program Officer

United Nations and Other International Organisations

United Nations

Mr Antonio Guterres, Secretary-General

Coalition for Epidemic Preparedness Innovations

Mr Richard Hatchett, CEO

Islamic Development Bank

Mr Amadou Thierno Diallo, Ag Director General Global Practices

Organization of Islamic Cooperation

Mr Askar Mussinov, Assistant Secretary General

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Mr Peter Sands, Executive Director

Ms Francoise Vanni, Director of External Relations and Communications

Ms Dianne Stewart, Head Donor Relations Department

UNAIDS

Mrs Rosemary Museminali, Director External and Donor relations

UNITAID

Dr Philippe Duneton, Executive Director

Civil Society Organisations

Amref Health Africa

Ms Desta Lakew, Director of Partnerships for Africa

Dr Githinji Gitahi, Group CEO/Director-General

CHIP

Ms Lubna Hashmat, CEO

GFF CSO Hub @PAI

Mrs Maty Dia, Partnership Manager

The Global Goals & ONE.org

Mr Jamie Drummond, Global Strategist & Co-Founder

International Committee of the Red Cross (ICRC)

Mr Charles Deutscher, Adviser

ISGlobal (Barcelona Institute for Global Health)

Mr Rafa Vilasanjuan, Director of Policy and Development

Latter-Day Saint Charities

Mr Robert Hokanson, Manager

Lions Clubs International

Mrs Gudrun Gjoert Yngvadottir, LCIF Chairperson/Immediate Past International President

The ONE Campaign

Ms Gayle Smith, CEO

Ms Romilly Greenhill, UK Director

PATH

Dr David Kaslow, VP, Essential Medicines & Head, Center for Vaccine Innovation and Access

Public Health Initiative Liberia

Ms Joyce L. Kilikpo, Executive Director

RESULTS

Joanne Carter, Executive Director

RESULTS UK

Mr Aaron Oxley, Executive Director

Rotary International

Mr. Michael McGovern, International PolioPlus Committee Chair

Save the Children UK

Mr Kevin Watkins, CEO

Speak Up Africa

Mrs Fara Ndiaye, Deputy Executive Director

Unicef UK

Mr Sacha Deshmukh, Executive Director

Ms Joanna Rea, Director of Advocacy

Union for International Cancer Control

HRH Princess Dina Mired, President

Dr Cary Adams, Chief Executive Officer

Women Deliver

Ms Katja Iversen, President/CEO

Pharmaceutical Industry, Private Sector, Foundations, Other Partners

ABPI

Dr Richard Torbett, Chief Executive

Academia Sinica

Dr James C Liao, President

Agility

Mr Tarek Sultan Al Essa, Vice-Chairman and Chief Executive Officer

Alwaleed Philanthropies

Ms Abeer Al Fouti, Executive Manager of Global Intiatives

Mrs Rana Alturaifi, Assistant Manager

AstraZeneca

Mr Pascal Soriot, CEO

Mr Sjoerd Hubben, Vice President Global Government Affairs and Policy

Avon Medical Practice

Dr Awele Elumelu, Chief Executive Officer

Bharat Biotech

Mr Sai Prasad, President

Biological E. Limited

Ms Mahima Datla, Managing Director

Bio-Manguinhos

Mrs Priscila Ferraz, Deputy Director of Management and Market

British Society for Immunology

Prof Arne Akbar, President

China National Biotec Group Company Limited

Mr Yonglin WU, President

Dr Xiaoming YANG, Chairman

Crescent Enterprises

Mr Badr Jafar, CEO

DAS Group of Companies, Part of Omnicom

Mrs Emma Sergeant, President, Europe

DCVMN

Mr. Sai D. Prasad, President

Dr. Sonia Pagliusi, Executive Secretary

DP DHL

Mr Thomas Ellmann, Vice President, Life Sciences and Healthcare, CSI

Eli Lilly and Company

Mr David Ricks, Chairman and CEO

The ELMA Philanthropies Services (U.S.) Inc

Ms Robyn Calder, Executive Director

The END Fund

Ms. Ellen Agler, CEO

EuBiologics Co., Ltd.

Dr Yeongok Baik, CEO

Facebook

Dr Praveen Raja, Head of Health Partnerships

Girl Effect

Mrs Nicky Davies, Head of Programmes

Mr Jonathan McKay, Acting CEO and Head of Product

GlaxoSmithKline

Ms Emma Walmsley, Chief Executive Officer

IFPMA

Mr Thomas Cueni, Director General

Mrs Laetitia Bigger, Vaccines Policy Director

International Federation of Pharmaceutical Wholesalers

Mr Mark Parrish, President and CEO

International Vaccine Institute

Dr Jerome Kim, Director General

IRD Global Limited

Dr Aamir Javed Khan, Executive Director

"La Caixa" Foundation

HRH The Infanta Cristina Of Spain Y Grecia, Director Of International Area

Laerdal Finans

Mr Gudleik Njaa, Chief Executive Officer

Laerdal Medical and Laerdal Global Health

Mr. Tore Laerdal, Chairman of the Board

Last Mile Health

Dr Raj Panjabi, Chief Executive Officer

LG CHEM

Dr Jeewoong Son, President

Liverpool School of Tropical Medicine

Prof David Lalloo, Director of LSTM

Living Goods

Mr Chuck Slaughter, Founder – Chairman

Mrs Liz Jarman, CEO

London School of Hygiene & Tropical Medicine

Professor Peter Piot, Director

Prof Heidi Larson, Professor and Director, The Vaccine Confidence Project

Mastercard

Mr Michael Froman, Vice Chairman and President Strategic Growth

Mrs Louise Holden, Vice President H&D, Mastercard UK

MSD

Dr John Markels, President, Global Vaccines

NEC CorporationHon

Mr Toshiya Matsuki, Executive Vice President

Nexleaf Analytics

Dr Nithya Ramanathan, CEO & Co-Founder

Office of David Cameron

Mr David Cameron, Former UK Prime Minister

Ms Jess Cunniffe, Office of David Cameron

Orange MEA

Mr Ralph Ankri, Senior Program Manager & Business Development

Panacea Biotec Limited

Dr Rajesh Jain, Managing Director

Pfizer

Mr Darius Hughes, Head of Vaccines UK

Ms. Susan Silbermann, Global President, Pfizer Emerging Markets

Dr Albert Bourla, Chairman and Chief Executive Officer

Polio Independent Monitoring Board

Professor Liam Donaldson, Chairman

RockCreek

Ms Afsaneh Beschloss, Gavi Board Member

Roxbury Asset Management Limited

Mr Stephen Zinser, Chief Executive

Royal Institute on International Affairs

Professor David Salisbury, Associate Fellow, Programme for Global Health

Sanofi Pasteaur

Mr David Loew, CEO

Mr Stuart Carroll, Head of Market Access, UK and Ireland

Serum Institute of India Pvt.Ltd.

Dr Cyrus Poonawalla, Chairman and Managing Director

Mr Adar Poonawalla, CEO

Dr Suresh Jadhav, Executive Director

SEB

Mr Johan Torgeby, CEO

Simprints

Dr Toby Norman, CEO & Co-Founder

SV Health Managers LLP

Mrs Kate Bingham, Chair of the UK Vaccine Taskforce & Managing Partner, SV Health Managers LLP

Temasek

Mr Yibing Wu, Senior Managing Director, Joint Head of Enterprise Development Group; Head of China

Trinity College

Dame Sally Davies, Master

Dr Connor Rochford, Policy and Strategy Adviser

Unilever

Mr Alan Jope, Chief Executive Officer

Mrs Rebecca Marmot, Chief Sustainability Officer

Ms Helena Dollimore, Senior Manager, Global Sustainability, Unilever

United Nations Foundation

Ms Martha Rebour, Executive Director, Shot@Life

Ambassador Elizabeth Cousens, President & Chief Executive Officer

University College London

Prof Arne Akbar, Professor of Immunology

University of the Witwatersrand

Dr Marta Nunes, Associate Professor

UPS

Mr Joe Ruiz, Director, UPS Humanitarian Relief & Resilience

The UPS Foundation

Mr Eduardo Martinez, President, The UPS Foundation & Chief Diversity and Inclusion Office, UPS

Villas Somalia

Mr Abdirashid Hashi, Media Director

Walvax Biotechnology CO.,LTD.

Mr Yunchun Li, Board Chairman

Wellcome Trust

Dr Charlie Weller, Head of Vaccines

Ms Anna Mouser, Policy and Advocacy Lead - Vaccines

Wits Reproductive Health and HIV Institute (Wits RHI)

Professor Helen Rees, Executive Director

Xiamen Innovx Biotech CO., Ltd.

Mr Yongzhong (Steven) Gao, General Manager

IFFIm Board of Directors

Mr Cyrus Ardalan, Chair

Gavi Board

Dr Ngozi Okonjo-Iweala, Chair

William Roedy, Independent Individual

Margaret (Peggy) Hamburg, Independent Individual

Helen Rees, Independent Individual

David Sidwell, Independent Individual

Stephen Zinser, Independent Individual

Teresa Ressel, Independent Individual

Yibing Wu, Independent Individual

Afsaneh Beschloss, Independent Individual

Orin Levine, Bill & Melinda Gates Foundation

Violaine Mitchell, Bill & Melinda Gates Foundation (Alternate)

Muhammad Pate, World Bank

Michael Kent Ranson, World Bank (Alternate)

Omar Abdi, UNICEF

Etleva Kadilli, UNICEF (Alternate)

Zsuzsanna Jakab, WHO

Kate O’Brien, WHO (Alternate)

Amir Aman Hagos, Developing Countries (Ethiopia & Ghana)

Kwaku Agyeman-Manu, Developing Countries (Ethiopia & Ghana) (Alternate)

Myint Htwe, Developing Countries (Myanmar & Lao PDR)

Bounkong Syhavong, Developing Countries (Myanmar & Lao PDR) (Alternate)

Ferozuddin Feroz, Developing Countries (Afghanistan & Pakistan)

Assad Hafeez, Developing Countries (Afghanistan & Pakistan) (Alternate)

Arsen Torosyan, Developing Countries (Armenia & Honduras)

Edna Yolani Batres, Developing Countries (Armenia & Honduras) (Alternate)

Mahamoud Youssouf Khayal, Developing Countries (Chad & Republic of Congo)

Jacqueline Lydia Mikolo, Developing Countries (Chat & Republic of Congo) (Alternate)

Jan Paehler, Donor Countries (Germany/France/Luxembourg/EC/Ireland)

Joan Valadou, Donor Countries (Germany/France/Luxembourg/EC/Ireland) (Alternate)

Francesca Manno, Donor Countries (Canada/Italy/Spain)

Megan Cain, Donor Countries (Canada/Italy/Spain) (Alternate)

Harriet Pedersen, Donor Countries (Norway/The Netherlands/Sweden)

Noor Khan, Donor Countries (Norway/The Netherlands/Sweden) (Alternate)

Daniel Graymore, Donor Countries (UK/Qatar)

Susan Elden, Donor Countries (UK/Qatar) (Alternate)

Sarah Goulding, Donor Countries (US/Australia/Japan/Rep. of Korea) / Vice Chair

Irene Koek, Donor Countries (US/Australia/Japan/Rep. of Korea) (Alternate)

Susan Silbermann, Vaccine Industry – Industrialised

An Vermeersch, Vaccine Industry – Industrialised (Alternate)

Sai Prasad, Vaccine Industry – Developing

Mahima Datla, Vaccine Industry – Developing (Alternate)

Maty Dia, CSOs

Rafael Vilasanjuan, CSOs (Alternate)

Marta Nunes, Research & Technical Health Institutes

William Schluter, Research & Technical Health Institutes (Alternate)

Dr Seth Berkley, Chief Executive Officer

Gavi Secretariat

Dr Seth Berkley, Chief Executive Officer

Mrs Anuradha Gupta, Deputy Chief Executive Officer

Mr Pascal Barollier, Managing Director, Public Engagement & Information Services

Mrs Assietou Diouf, Managing Director Finance & Operations

Mr Simon Lamb, Managing Director Audit & Investigations

Mr Thabani Maphosa, Managing Director Country Programmes

Ms Aurélia Nguyen, Managing Director, Vaccines & Sustainability

Ms Marie-Ange Saraka Yao, Managing Director, Resource Mobilisation, Private Sector Partnerships &

Innovative Finance, Replenishment Chair

Mr Guillaume Grosso, Director, International Business Development & European Strategy,

Replenishment Co-Chair

Ms Li Zhang, Director, Strategic Innovation & New Investors, Replenishment Co-Chair

Mrs Natasha Bilimoria, Director, US Strategy

Mrs Laura Boehner, CTKO

Ms Hannah Burris, Chief of Staff

Mr Paolo Sisson, Director, Innovative Finance

Mr Seb Meaney, Head, UK Strategy

Mr Daniel Thornton, Replenishment Project Manager